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Benign ﬁbrous histiocytoma is an interesting and challenging entity even in its most usual, cutaneous presentation. Noncutaneous
presentation is extremely limited, even more so for the mucosa of the head and neck area. We herein report such a case, describing
the clinical characteristics of the lesion, complete diagnostic evaluation, management, and follow-up. Diagnostic histopathological
challenges are speciﬁcally illustrated. A complete review of the relevant literature is also included.
1.Introduction
The benign ﬁbrous histiocytoma (BFH) is a mesenchymal
tumour that has been described as a benign neoplasm com-
posed of ﬁbroblasts and histiocytes arising in the cutaneous
and noncutaneous soft tissues [1]. Because of the confusion
over the natural history of ﬁbrohistiocytic lesions, BFH was
not identiﬁed as a separate clinical entity until the 1960s
[2]. Cutaneous BFH commonly originates in sun-exposed
skin. Non-cutaneous BFH represents approximately 1% of
all benign FH lesions [3], and most frequently occurs in the
soft tissues in the lower extremities (50%), less frequently
in the upper extremities (20%), retroperitoneum (20%)
[4].
The occurrence of this lesion in deep soft tissues of the
h e a da n dn e c kh a sb e e nr a r e l yr e p o r t e d[ 2, 5]. An exception
to this is BFH arising in the orbital tissues, representing the
most frequent primary mesenchymal tumour of the orbit
in adult patients [4, 6]. In the rest of the head and neck
area, non-cutaneous BFH may arise in the buccal spaces,
but cases of BFH of the tongue [7, 8], gingival or alveolar
ridge [9, 10], mandible [11], maxilla [12], lower and upper
lips, soft palate [13], and ﬂoor of the mouth have also
been described [14]. Rare occurrences also include the nasal
cavity and paranasal sinuses [15–17], larynx [18], trachea
[19], temporomandibular joint [20], and submandibular
and parotid glands [21–23]. It most often develops as a
painless mass with speciﬁc symptoms caused by interference
withthenormalanatomyandphysiologyoftheareainwhich
they arise [2, 5]. Interestingly, primary BFH has recently also
been reported in the mandibular bone [24–26].
In contrast to malignant ﬁbrous histiocytoma (MFH),
benign ﬁbrous histiocytoma of the noncutaneous soft tissues
of the head and neck has received little attention in the head
and neck surgical literature.
BFH is seen mainly in adults and most frequently in
young and middle aged women. Patients are usually under
50 years of age and have a history of sun exposure, trauma,
or chronic infection, suggesting that BFH is a reactive disease
[5, 9, 13].
This article describes a case of BFH of the buccal mucosa
and discusses its clinical and pathological characteristics and
management.2 Case Reports in Medicine
Figure 1: Buccal mucosa BFH: Preoperative view of the lesion.
Figure 2: Buccal mucosa BFH: Intraoperative view of the lesion.
2.CaseReport
A 36-year-old man was referred to the Department of Oral
and Maxillofacial Surgery of “Theagenio” Cancer Hospital
for an asymptomatic, slowly growing nodular lesion on the
right buccal mucosa that had been present for approximately
one year. His medical history was noncontributory. Exam-
ination revealed a well-circumscribed, moderately mobile,
nontender ﬁbroelastic lump of approximately 3cm in diam-
eter. The mucosal surface appeared smooth and moderately
inﬂammatory, possibly due to local trauma (Figure 1).
The patient underwent an intraoral excision of the mass
under general anesthesia with primary closure. On surgical
excision the mass was easily dissected from the surrounding
tissues (Figure 2).
Histologic analysis of the specimen revealed a macro-
scopicallysmooth,well-circumscribedencapsulatedlesionof
2.4cm in greatest dimension. The mass was grossly round in
appearance,withawhitegreysurface(Figure 3).Microscopi-
callythetumourwascomposedofﬁbroblast-likespindlecells
with fascicular and focallystoriform arrangement (Figure 4).
Plump, polygonal histiocytic cells were found among the
spindlecells.Therewerenomitoticﬁgures,cellularpleomor-
phism, multinuclear giant cells, nuclear atypia or necrosis.
The stroma was collagenised and demonstrated a rich
vascularity. There was a scattered inﬂammatory inﬁltrate
predominantly composed of lymphocytes and plasma cells.
Figure 3: Buccal mucosa BFH: Surgical resection specimen.
Figure 4: Spindle-shaped cells in a storiform pattern (H&E stain,
×40).
The tumour cells showed strong immunoreactivity for
vimentin, weak and focal immunoreactivity for CD34
(Figure 5) and some tumour cells (histiocyte-like) were
positive for CD68 (KP 1) (Figure 6). There was negativity for
desmin, alpha smooth muscle actin (α-SMA), S-100 protein,
Leu7, and CD117 (c-kit).
TheﬁnaldiagnosiswasBFH.Thepatientwasfreeofloco-
regional disease at 12-month follow-up.
3. Discussion
Pathologic analysis and diagnosis of this type of lesions is
oftenchallengingandusuallybasedonacombinationoflight
microscopy and immunohistochemistry [4].
Until recently the term ﬁbrous histiocytoma (FH)
referred to both benign and malignant neoplasms. The
diﬀerential diagnosis between the two entities was often
diﬃcult [4]. The so-called malignant FH is not a deﬁnable
entity but instead represents a wastebasket of undiﬀerenti-
ated pleomorphic sarcomas accounting for no more than 5%
of adult soft tissue sarcomas. Although retained in the 2002
WHO classiﬁcation of soft tissue tumours, it has long been
recognised that these tumours have no relationship to true
histocytes [27]. The benign ﬁbrous histiocytoma also has a
controversial diagnosis because of its uncertain histogenesis
[2, 4, 11].Case Reports in Medicine 3
Figure 5: Spindle-shaped tumour cells were positive for CD34
(diaminobenzidine, ×400).
Figure 6: Histiocyte-like tumour cells were positive for CD68
(diaminobenzidine, ×400).
Due to the lack of speciﬁc markers for ﬁbrohistiocytic
lesions, the diagnosis of BFH is generally based on the
absence of markers for cells of other lineages [4]. Immuno-
histochemical staining and ultrastructural examination of
the tumours and cell lines derived from them has revealed
features of myoblastic and histiocytic diﬀerentiation as
evidence of mesenchymal origin [4]. Immunostaining for
CD68 can be found in any tumour-containing lysosomal
granules or phagolysosomes as in our case [4]. Factor XIIIα
has occasionally been reported for BFH [28].
In the present study, the diagnosis was conﬁrmed using
immunostaining for vimentin (+), CD68 (+), CD34 (+), S-
100 (−), CD117 (−), Leu7 (−), desmin (−), and α-SMA (−).
Histopathologically, BFH typically shows a biphasic cell
population of histiocytes and ﬁbroblasts [28]. In some cases
the cells resemble myoﬁbroblasts, primitive mesenchymal
cells, and cells having intermediate or mixed features. The
presence of a homogeneous population of ﬁbroblast-like
cells has also been described [2]. Our case showed biphasic
population with predominance of ﬁbroblast-like spindle
cells. Other histological features frequently described in BFH
are the presence of multinucleated giant cells, abundant
vascularity, and inﬂammatory inﬁltrate [2]. The main dif-
ferential diagnosis of oral BFH includes nodular fasciitis,
solitary ﬁbrous tumour (SFT), neuroﬁbroma (NF), and
dermatoﬁbroma (DF) [29]. CD34 positivity is a useful aid
for distinction between BFH and SFT, the former reported as
Table 1: Buccal mucosa BFH: review of the literature.













8 M LE 14 NED
Bielamowicz et
al., 1995 [2] 25 M LE 24 NED
Femiano et al.,
2001 [4] 32 M LE ∗∗ ∗∗
Alves et al.,
2003 [29] 26 F LE 24 NED
LE: Local excision; FU: Follow-up; NED: No evidence of disease.
∗Full-textarticlenotavailabletoauthors.CasereportedintheHoﬀmanand
Martinez (1981) paper [9]
∗∗Information not available in the original article.
usuallynegative[8],althoughinourcasethetumourshowed
weak immunoreactivity. Diﬀerentiation between BFH and
NF can be based on S-100 positivity, more frequent mitoses
and diﬀerent fascicle conﬁguration for the latter [29, 30].
BFH and DF show similar immunoreactivity [29, 31]. The
negativity for SMA and S-100 could diﬀerentiate the lesion
from leiomyosarcoma and neurogenic tumours [32].
The treatment of choice is the complete resection of
tumour, with an excellent prognosis and recurrence rate of
almost zero [31, 34]. Fewer than 5% of cutaneous ﬁbrous
histiocytomas recur following local excision, and in the
m o u t hm o s tr e p o r t e dc a s e sf e a t u r e dn or e c u r r e n c e s[ 35].
BFH does not have metastatic potential [31, 34].
A review of the literature identiﬁed additional 6 cases
of buccal mucosa BFH (Table 1). Most lesions were treated
by a local excision without sacriﬁcing structures that would
cause major functional or cosmetic morbidity. One further
paper reporting BFH of the oral mucosa was identiﬁed
[36], however full-text article was not available to us for
veriﬁcation of the exact location of the tumours.
4. Conclusion
We reported the clinical, microscopic, and immunohisto-
chemical aspects of a case of BFH of the buccal mucosa.
Although rare, BFH must be considered in the diﬀerential
diagnosis of oral soft tissue tumors.
The prognosis of BFH is excellent. The results of this
study support local excision as deﬁnitive treatment of
BFH of buccal mucosa. When pathologically clear margins
are found, the incidence of local recurrence is unlikely.
Incomplete excision or enucleation may result in signiﬁ-
cant percentage of recurrence [37]. Radiation therapy and
chemotherapy have currently no role in the management of
BFH.4 Case Reports in Medicine
A thorough knowledge of this lesion is important to
the head and neck surgeon, who will provide the primary
management of this rare lesion.
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